ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Promising early results for BMS’ investigational HCC study pharmatimes
June 05, 2019Bristol-Myers Squibb (BMS) has announced the first results from its investigational Opdivo (nivolumab) plus Yervoy (ipilimumab) cohorts of the Phase I/II CheckMate -040 study at the American Society of Clinical Oncology (ASCO) meeting 2019.
Pharma Sources Insight January 2025
